UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057599
Receipt number R000065812
Scientific Title Test of suppression of postprandial blood glucose elevation by food ingestion
Date of disclosure of the study information 2025/04/15
Last modified on 2025/04/12 17:16:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Test of suppression of postprandial blood glucose elevation by food ingestion

Acronym

Test of suppression of postprandial blood glucose elevation by food ingestion

Scientific Title

Test of suppression of postprandial blood glucose elevation by food ingestion

Scientific Title:Acronym

Test of suppression of postprandial blood glucose elevation by food ingestion

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the inhibitory effect of test foods on postprandial blood glucose elevation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in postprandial blood glucose levels

Key secondary outcomes

Changes in postprandial insulin


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Single intake of bitter melon and foods containing corosolic acid

Interventions/Control_2

Single intake of placebo foods containing corosolic acid

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Male and female subjects aged 20 to 64 years
(2) Normal to slightly elevated fasting blood glucose level (125 mg/dL or less) at baseline
(3) Subjects who give written voluntary consent to participate in the study

Key exclusion criteria

(1) Those who have been diagnosed with diabetes and are currently undergoing treatment
(2) Those who are currently taking medication for diabetes or high blood pressure
(3) Those who are currently taking the test food or health food
(4) Those who regularly take supplements related to cholesterol, blood pressure, blood lipids, or blood sugar levels
(5) Those with serious diseases or mental disorders of the following systems: sugar metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system. Those with a history of such diseases or disorders
(6) Those who have been found to have abnormal clinical test values and are judged to have problems participating in the study
(7) Those with diseases that are currently being treated or who have a history of serious diseases that required medication treatment
(8) Those who may develop allergies in relation to the study
(9) Those who are judged to be unsuitable as subjects based on the results of the lifestyle questionnaire
(10) Those who are participating in other clinical research at the start of this study
(11) Those who are pregnant or plan to become pregnant or breastfeed during the study period
(12) Those who are judged to be unsuitable for participation in the study by the principal investigator (or the person in charge of conducting the study)

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Ryuji
Middle name
Last name Takeda

Organization

Kansai University of Welfare Sciences

Division name

Department of Nutritional Sciences for Welll-being, Faculty of Health Science for Welfare

Zip code

582-0026

Address

Asahigaoka 3-11-1, Kashiwara, Osaka

TEL

072-978-0088

Email

rtakeda@tamateyama.ac.jp


Public contact

Name of contact person

1st name Shigefumi
Middle name
Last name Nibun

Organization

EAS inc.

Division name

Clinical Trial Session

Zip code

236-0028

Address

Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa

TEL

070-5415-3051

Homepage URL


Email

info@eas-ct.jp


Sponsor or person

Institute

Lifix Corporation

Institute

Department

Personal name



Funding Source

Organization

Lifix Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

KOBUNA ORTHOPEDIC SURGERY

Address

311-2, Gokan-machi, Maebashi, Gunma

Tel

027-261-7600

Email

sagawa@mc-connect.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 02 Month 10 Day

Date of IRB

2025 Year 02 Month 20 Day

Anticipated trial start date

2025 Year 04 Month 14 Day

Last follow-up date

2025 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 12 Day

Last modified on

2025 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065812